logo-loader

iAnthus Capital issues US$500,000 promissory note to Citiva

Last updated: 09:05 21 Aug 2017 EDT, First published: 04:05 21 Aug 2017 EDT

Dollar bill
The promissory note has a term of one year, subject to acceleration in certain events, and yields interest at a rate of up to 20%

iAnthus Capital Holdings Inc (CSE:IAN, OTCQB:ITHUF), which last week announced the acquisition of Citiva Medical, has advanced US$500,000 to the medical marijuana cultivation licences holder.

The money was advanced pursuant to a secured promissory note that has a one-year term and which yields interest at a rate of up to 20%.

The promissory note was financed in connection with the letter of intent to acquire Citiva.

READ iAnthus Capital set to expand into five US states with US$18mln Citiva deal

 

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

12 minutes ago